Prof. Dr. Sezer Sağlam
Est-ce votre profil ? Revendiquez-le et vérifiez vos informations.
Revendiquer le profilCV
Formation et expérience
Formation
- 2005İstanbul Üniversitesi Onkoloji Enstitüsü, Medikal Onkoloji Uzmanlık Eğitimiflorence.com.tr
- 1996-1997Cerrahpaşa Tıp Fakültesi, Hemodiyaliz Eğitimiflorence.com.tr
- 1991-1996Cerrahpaşa Tıp Fakültesi, İç Hastalıkları Uzmanlık Eğitimiflorence.com.tr
- 1991Ege Üniversitesi, Tıp Eğitimiflorence.com.tr
Confiance
D’où viennent ces informations ?
La source est indiquée à côté de chaque information. Si vous constatez une erreur, vous pouvez suggérer une correction.
- SpécialitéOncologie médicaleflorence.com.trD’après la source
- Nom du service dans la sourceMedikal Onkolojiflorence.com.trD’après la source
- ÉtablissementGayrettepe Florence Nightingale Hastanesiflorence.com.trD’après la source
- Publications33 publicationspage de profil sur florence.com.trD’après la source
- Dernière synchronisation7 novembre 2026 07:19https://www.florence.com.tr/doktorlar/prof-dr-sezer-saglamflorence.com.tr
Travaux scientifiques
Publications
-
Topuz E, Eralp Y, Saglam S, Saip P, Aydiner A, Berkman S, Yavuz E. "Efficacy of intraperitoneal cisplatin as consolidation therapy in patients with pathologic complete remission following front-line therapy for epithelial ovarian cancer. Consolidative intraperitoneal cisplatin in ovarian cancer."Gynecol Oncol. 92(1): 147–5, 2004.
Source : page de profil sur florence.com.tr
-
Balci NC, Akun E, Erturk M, Saglam S, Inan N, Balci Y. "Renal-related perinephric fluid collections: MRI findings." Magn Reson Imaging. 23(5): 679–84, 2005.
Source : page de profil sur florence.com.tr
-
Basaran M, Bavbek ES, Saglam S, Eralp L, Sakar B, Atalar AC, Bilgic B, Ozger H, Onat H. "A phase II study of cisplatin, ifosfamide and epirubicin combination chemotherapy in adults with nonmetastatic and extremity osteosarcomas." Oncology. 72(3–4): 255–60, 2007.
Source : page de profil sur florence.com.tr
-
Sakar B, Gumus M, Basaran M, Argon A, Ustuner Z, Ustaoglu MA, Saglam S, Guney N, Tenekeci AN, Aykan NF. "XELOX followed by XELIRI or the reverse sequence in advanced colorectal cancer." Oncology. 73(5–6): 298–304, 2007.
Source : page de profil sur florence.com.tr
-
Topuz E, Derin D, Can G, Kürklü E, Cinar S, Aykan F, Cevikbaş A, Dişçi R, Durna Z, Sakar B, Saglam S, Tanyeri H, Deniz G, Gürer U, Taş F, Guney N, Aydiner A. "Effect of oral administration of kefir on serum proinflammatory cytokines on 5-FU induced oral mucositis in patients with colorectal cancer." Invest New Drugs. 26(6): 567–72, 2008.
Source : page de profil sur florence.com.tr
-
Balci NC, Befeler AS, Bieneman BK, Fattahi R, Saglam S, Havlioglu N. "Fat containing HCC: findings on CT and MRI including serial contrast-enhanced imaging." Acad Radiol. 16(8): 963–8, 2009.
Source : page de profil sur florence.com.tr
-
Balci NC, Perman WH, Saglam S, Akisik F, Fattahi R, Bilgin M. "Diffusion-weighted magnetic resonance imaging of the pancreas." Top Magn Reson Imaging. 20(1): 43–7, 2009.
Source : page de profil sur florence.com.tr
-
Saglam S, Suzme R, Gurdol F. "Serum tumor necrosis factor-alpha and interleukin-2 concentrations in newly diagnosed ERBB2 (HER2/neu) positive breast cancer patients." Int J Biol Markers. 24(3): 142–6, 2009.
Source : page de profil sur florence.com.tr
-
Saglam S,Aykan NF,Şakar B et al. A pilot study evaluating the safety and toxicity of epirubicin, cisplatin, and UFT (ECU regimen) in advanced gastric carcinoma. Journal of Gastrointestinal Oncology.2; 219-26, 2011
Source : page de profil sur florence.com.tr
-
Effects of surgical laparoscopic experience on the short-term postoperative outcome of rectal cancer: results of a high volume single center institution.Balik E, Asoglu O, Saglam S, Yamaner S, Akyuz A, Buyukuncu Y, Gulluoglu M, Bulut T, Bugra D. Surg Laparosc Endosc Percutan Tech. 2010;20:93-9.
Source : page de profil sur florence.com.tr